ALVAC-hIL-2

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameALVAC-hIL-2
Drug Alias NamevCP277ALVAC-IL-2ALVAC-hIL-2
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Canarypox viral vector
Mechanisms of ActionInterleukin-2 stimulants
TargetsInterleukin-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Pasteur
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A